KalVista Pharmaceuticals (KALV) Assets Average (2016 - 2024)
Historic Assets Average for KalVista Pharmaceuticals (KALV) over the last 9 years, with Q4 2024 value amounting to $227.8 million.
- KalVista Pharmaceuticals' Assets Average changed N/A to $227.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $227.8 million, marking a year-over-year change of. This contributed to the annual value of $105.3 million for FY2020, which is 1734.62% up from last year.
- As of Q4 2024, KalVista Pharmaceuticals' Assets Average stood at $227.8 million.
- KalVista Pharmaceuticals' 5-year Assets Average high stood at $227.8 million for Q4 2024, and its period low was $70.8 million during Q1 2021.
- Moreover, its 4-year median value for Assets Average was $119.8 million (2023), whereas its average is $136.2 million.
- In the last 5 years, KalVista Pharmaceuticals' Assets Average plummeted by 3411.41% in 2021 and then surged by 9228.65% in 2024.
- Over the past 4 years, KalVista Pharmaceuticals' Assets Average (Quarter) stood at $79.7 million in 2020, then dropped by 11.11% to $70.8 million in 2021, then surged by 111.13% to $149.5 million in 2023, then surged by 52.35% to $227.8 million in 2024.
- Its Assets Average was $227.8 million in Q4 2024, compared to $180.5 million in Q4 2024 and $217.8 million in Q3 2024.